查,测试,诊断和治疗D型肝炎 (三角形) 病毒患者的最佳实践,基于全球专家审查和最新指南
Markus Cornberg1,2, Fabien Zoulim3, Robert Gish4
1Department of Gastroenterology, Hepatology, Infectious Diseases and Endocrinology, Hannover Medical School, Germany.
Antiviral therapy
|September 30, 2025
概括
肝炎D病毒 (HDV) 是最严重的肝炎,需要对所有肝炎B表面抗原 (HBsAg) 阳性个体进行早期查. 新的指导方针建议布莱维尔提德用于长期的HDV管理,并且正在出现量身定制的组合疗法.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 病毒学 病毒学
- 传染性疾病 传染性疾病
背景情况:
- 肝炎D病毒 (HDV) 感染意味着病毒性肝炎的最严重形式.
- 高密度病毒与快速发育的肝硬化和肝脏相关死亡率的增加有关.
- 据估计,全球约有900万至1900万人患有HDV阳性.
研究的目的:
- 更新目前的HVD管理格局.
- 为 HDV 查,诊断和抗病毒治疗提供建议.
- 将最近的证据和临床指南的发展纳入专家的共识.
主要方法:
- 一份专家的共识文件被制订出来.
- 建议来源于一个结构化的专家小组讨论.
- 纳入了最近的证据和临床指南的发展.
主要成果:
- 在HBsAg阳性个体中进行系统的HDV查至关重要.
- 治疗目标包括持续的HDV-RNA抑制和HBsAg损失.
- 推使用布列维尔提德作为长期单一疗法; PEG-IFNα的使用应受到限制和量身定制.
结论:
- 为HDV查,诊断和治疗提供了最新的建议.
- 布列维尔提德在当前的HDV管理中发挥着关键作用.
- 突出了个性化治疗方法和未来的组合疗法.
相关概念视频
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
185
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
185
Standard Precaution
2.8K
Standard precautions are the minimum infection control safeguards used while caring for all patients, irrespective of their disease condition. They help prevent the spread of common infectious microorganisms to healthcare workers, patients, and visitors in all healthcare settings.
Hand hygiene is the most crucial means to prevent the transmission of disease. Employers are legally required to provide their workers with personal protective equipment (PPE) to minimize exposure or contact with...
Hand hygiene is the most crucial means to prevent the transmission of disease. Employers are legally required to provide their workers with personal protective equipment (PPE) to minimize exposure or contact with...
2.8K
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
214
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
214
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
256
Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
256
Diseases of the Liver and Gallbladder
1.9K
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
1.9K
Healthcare Associated Infections II: Preventive Measures
3.6K
Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
3.6K


